Table 1.
Trade name | Marketing company | Product components | Regenerative triad elements | Approval authority | Date of approval |
---|---|---|---|---|---|
Polyethylene glycol (PEG) | Scaffold | FDA | Pre 2010 | ||
Polylactic acid (PLA) | Scaffold | FDA | Pre 2010 | ||
Polylactide‐glycolic acid (PLGA) | Scaffold | FDA | Pre 2010 | ||
Carticel® | Vericel | Autologous chondrocytes | Cells | FDA | Pre 2010 |
SaluCartilage™ | Salumedica | Poly‐vinyl alcohol (PVA) hydrogel | Scaffold | EMA, FDA | Pre 2010 |
CaReS® | Arthrokinetics | Autologous chondrocytes and type 1 collagen | Cells and scaffold | EMA | Pre 2010 |
MACI® | Vericel | Autologous chondrocytes and porcine collagen | Cells and scaffold | FDA | Post 2010 |
BST‐Cargel® | Smith & Nephew | Chitosan polysaccharide | Liquid scaffold | EMA | Post 2010 |
GelrinC | Reagentis Biomaterials | Polyethylene glycol diacrylate (PEG‐DA) and denatured fibrinogen, crosslinked with UVA light | Scaffold | EMA | Post 2010 |
Agili‐C™ | CartiHeal | Aragonite and hyaluronic acid | Biphasic scaffold | EMA | Post 2010 |